Report cover image

Global Atrial Fibrillation Surgery Devices Supply, Demand and Key Producers, 2026-2032

Publisher GlobalInfoResearch
Published Jan 05, 2026
Length 117 Pages
SKU # GFSH20766169

Description

The global Atrial Fibrillation Surgery Devices market size is expected to reach $ 4931 million by 2032, rising at a market growth of 9.7% CAGR during the forecast period (2026-2032).

Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Current treatments span a spectrum of non-invasive to highly invasive options and include medical and surgical variants. The success of the MAZE procedure and its successors has led to the development of surgical ablation devices designed to mark cardiac tissue in a manner similar to suture lines, thereby disrupting the path of the electrical impulses causing the patient’s AF

In terms of region, the largest segment of Atrial Fibrillation Surgery Devices Market would be North America, with a market share of over 40% in 2019. The follower is Europe accounted for nearly 27% of global market.

For the major players of Atrial Fibrillation Surgery Devices, Johnson & Johnson maintained its first place in the ranking in 2019. Followed by Abbott,Medtronic,Japan Lifeline,Boston Scientific etc.. The Top 5 players accounted for about 86% of the Atrial Fibrillation Surgery Devices revenue market share in 2019.

This report studies the global Atrial Fibrillation Surgery Devices production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Atrial Fibrillation Surgery Devices and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Atrial Fibrillation Surgery Devices that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Atrial Fibrillation Surgery Devices total production and demand, 2021-2032, (K Units)

Global Atrial Fibrillation Surgery Devices total production value, 2021-2032, (USD Million)

Global Atrial Fibrillation Surgery Devices production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)

Global Atrial Fibrillation Surgery Devices consumption by region & country, CAGR, 2021-2032 & (K Units)

U.S. VS China: Atrial Fibrillation Surgery Devices domestic production, consumption, key domestic manufacturers and share

Global Atrial Fibrillation Surgery Devices production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)

Global Atrial Fibrillation Surgery Devices production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)

Global Atrial Fibrillation Surgery Devices production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)

This report profiles key players in the global Atrial Fibrillation Surgery Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Abbott, Medtronic, Japan Lifeline, Boston Scientific, Atricure, Biotroik, OSYPKA AG, Cardiofocus, MicroPort EP MedTech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Atrial Fibrillation Surgery Devices market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Atrial Fibrillation Surgery Devices Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Atrial Fibrillation Surgery Devices Market, Segmentation by Type:
Catheter Ablation
Maze Surgery

Global Atrial Fibrillation Surgery Devices Market, Segmentation by Application:
Hospitals
Ambulatory Surgical Centers

Companies Profiled:
Johnson & Johnson
Abbott
Medtronic
Japan Lifeline
Boston Scientific
Atricure
Biotroik
OSYPKA AG
Cardiofocus
MicroPort EP MedTech
Synaptic Medical

Key Questions Answered:

1. How big is the global Atrial Fibrillation Surgery Devices market?

2. What is the demand of the global Atrial Fibrillation Surgery Devices market?

3. What is the year over year growth of the global Atrial Fibrillation Surgery Devices market?

4. What is the production and production value of the global Atrial Fibrillation Surgery Devices market?

5. Who are the key producers in the global Atrial Fibrillation Surgery Devices market?

6. What are the growth factors driving the market demand?

Table of Contents

117 Pages
1 Supply Summary
2 Demand Summary
3 World Manufacturers Competitive Analysis
4 United States VS China VS Rest of the World
5 Market Analysis by Type
6 Market Analysis by Application
7 Company Profiles
8 Industry Chain Analysis
9 Research Findings and Conclusion
10 Appendix
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.